ARCHIVES

FDA Approves Gleevec For First Line Rx Of CML

This article is from The Cancer Letter archive.

Vol. 26 No. 1 | January 31, 2003

Download PDF Visit The Full Archive

Related Articles

Addendum to RAID

December 17, 1999

In Brief: New NCAB Members Briefed At Orientation Wogan Resigns From Board; Parry Names NCCP Deputy

September 10, 1982

NCI Closes Iressa Trial For NSCLC When Data Indicate No Survival Benefit

April 29, 2005

In Brief: Survey Finds Most Localities Have Smoking Limits; Martocchio, Rickel ONS Award Speakers

April 24, 1987

Niass General’s Sanders Reported offered Asst. Secretary Job

February 18, 1977

Stand Up To Cancer Awards 13 Grants

January 15, 2010